Compare Macerich Company (The) Common Stock (MAC) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Macerich Company (The) Common Stock vs Zoetis Inc — how do they compare? Macerich Company (The) Common Stock trades at $22.58 (market cap $6.29B), while Zoetis Inc trades at $76.47 (market cap $31.11B). The key difference: Zoetis Inc is far larger — about 4.9× Macerich Company (The) Common Stock's market cap, and Macerich Company (The) Common Stock pays the higher dividend (3.07%). Which is the better fit depends on your goals — on Pluang, investors hold Macerich Company (The) Common Stock for 0 Days and Zoetis Inc for 71 Days on average.
| MAC | ZTS | |
|---|---|---|
Market Cap | $6.29B | $31.11B |
Volume | 3,158,142 | 2,515,954 |
Sector | Real Estate | Health |
52-Week High | $26.51 | $147.53 |
52-Week Low | $16.20 | $69.09 |
Typical Hold Time | 0 Days | 71 Days |
Enterprise Value | $10.97B | $38.68B |
Dividend Yield | 3.07% | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Zoetis (ZTS) trades at $74.3, down 1.78% on the day, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a net income margin of 27.69% and ROE of 64.91% for 2025, though recent quarterly earnings have been mixed. Revenue growth has been steady, reaching $9.47B in 2025, while valuation ratios like P/E of 12.28 suggest potential undervaluation relative to historical levels. Recent news highlights competitive pressures in the U.S. companion animal market but also underscores Zoetis's resilient margins.
The outlook for ZTS is cautiously optimistic, with a consensus price target of $87.33 implying significant upside. Key opportunities include its industry-leading margins and international growth, while risks involve heightened competition and weak U.S. pet care demand. Analyst sentiment is balanced with 46.88% buy ratings, but investors should monitor Q3 2026 earnings for confirmation of a turnaround.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Macerich Company (The) Common Stock
The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
